In your office and in the courtroom—you can find analysis of every patent law decision of the U.S. Court of Appeals for the Federal Circuit in this single-volume resource.
This monumental reference deals with both the high-profile cases and the “uncelebrated decisions” that tend to slip under the radar, and fits them into an analytical framework that reveals their true significance. The new Eleventh Edition of Patents and the Federal Circuit incorporates important new topics and discussions of: The AIA (America Invents Act, Biotechnology and patentable subject matter under 35 U.S.C. § 101, New standards for establishing induced infringement of method claims, and Mayo Collaborative Services v. Prometheus Labs and the Supreme Court’s ruling on the applicable test for determining the patentability of processes reciting laws of nature and its anticipated impact.
The 2014 Supplement includes:
- Discussion of all Federal Circuit patent law decisions through the end of 2013, plus major U.S. Supreme Court cases through June 2014, including:
- Nautilus, Inc. v. Biosig Instruments, Inc. (indefiniteness);
- Limelight Networks, Inc. v. Akamai Technologies, Inc. (divided infringement);
- Highmark Inc. v. Allcare Health Mgmt. Sys., Inc. (standard of review for exceptional case);
- Octane Fitness, LLC v. ICON Health & Fitness, Inc. (standard for determining exceptional case and award of attorneys’ fees);
- and Medtronic, Inc. v. Mirowski Family Ventures, LLC (burden of proof for infringement in licensing context)
- Review of the standard for patent eligible subject matter under 35 U.S.C. §101 across a variety of technological areas, including:
- genetics in Association for Molecular Pathology v. Myriad Genetics Inc.;
- processes in Ultramercial, Inc. v. Hulu, LLC and software in CLS Bank International v. Alice Corp. Pty. Ltd.;
- the line between state and federal jurisdiction in Gunn v. Minton, holding that legal malpractice claims will rarely, if ever, arise under federal patent law even if they require resolution of a substantive question of federal patent law;
- Bowman v. Monsanto Co., in which the Supreme Court held that the doctrine of patent exhaustion leaves untouched a patentee’s ability to prevent a buyer from making new copies of a patented item, which permitted Monsanto to prevent purchasers of its seeds from making additional patented soybeans for growing new crops
About the Publisher
Technology Transfer Tactics is proud to partner with Bloomberg BNA Books to bring our customers access to this comprehensive and authoritative resource. All Bloomberg BNA Books are written by respected experts with extensive experience in patent law and IP licensing. These renowned authors draw from their wealth of professional expertise and in-depth research to deliver the most highly regarded editorial quality in the industry.